Search PubMed⌕ Search

Biomedical subjects

L Larsen

Publications and source records attributed to L Larsen.

At least 73 records · Page 4Linked to original sources
PubMed1981

Neomycin toxicosis in calves.

Calves (n = 4) were given neomycin (2.25 or 4.5 mg/kg) twice daily IM and were compared with 2 calves given penicillin IM. The 2 hallmarks of aminoglycoside toxicosis, nephrotoxicosis and ototoxicosis, were seen with both dosages of parenterally administered neomycin. Nephrotoxicosis was confirmed by abnormal findings in urinalysis (granular casts, proteinuria, low specific gravity), renal biopsy results (tubular degeneration and necrosis), and increased 24-hour amounts of urinary enzymes (alanine aminopeptidase and gamma-glutamyltranspeptidase). Azotemia, decreased creatinine clearance, polyuria, and polydipsia also were documented in calves given neomycin. Clinically, deafness was suspected in 2 calves and was documented by electrical auditory-evoked response tests. Abnormalities in partial thromboplastin times and renal residues of neomycin were seen in all 4 calves that were given neomycin, but not in calves that were given penicillin.

Alanine Transaminase↗
PubMed1979

Epidemic of chancroid in Greenland 1977-78.

In Greenland there has been a rapid increase in the incidence of gonorrhoea and syphilis during past decades. In 1977 there was an epidemic of chancroid along the west coast of Greenland, with 975 cases reported from some 32,500 adults. The number of reported cases increased until October, 1977, and subsequently decreased. 186 patients were studied. Many of these had previously had gonorrhoea and syphilis. Male patients were both Eskimoan and Danish but female patients were solely Eskimoan. The sex ratio (M/F) was 1.6/1. The incubation period was 4 days in men and 13 days in women. Symptom-free female carriers did not seem to be an important reservoir of infection. 15% of the patients were admitted to hospital with buboes or extensive lesions. The clinical course was uncomplicated in most cases. Ulcers healed within a week of treatment with sulphonamide. Chancroid can be expected to disappear in Greenland within a short time.

Adolescent↗
PubMed1979

Iron absorption and iron status in patients with chronic uremia on regular peritoneal dialysis.

Gastrointestinal iron absorption was measured by whole body counting in 18 patients on regular peritoneal dialysis. Ten patients received regular oral iron treatment prior to the study (iron treated group), 8 patients did not receive iron treatment (non-iron treated group). Whole body retention 14 days after oral administration of 10 microCi 59Fe together with a carrier dose of 10 mg Fe2+ was used as an estimate of absorption. The erythrocyte iron incorporation, i.e. the percentage of administered 59Fe incorporated into the total erythrocyte mass, was measured. Geometric mean iron absorption in the non-iron treated groups was 7.4+/-3.3 (S.D.) % and in the iron treated group 2.8+/-2.5% (p less than 0.01). Absorption in the non-iron treated group did not differ significantly from the value in a normal control group (p greater than 0.3). Absorption in the iron treated group was distinctly lower than in the controls (p less than 0.01), due to the high iron supplementation. Several patients in the non-iron treated group had latent or overt iron deficiency, while patients in the iron treated group had satisfactory iron status. The correlation between iron absorption and erythrocyte iron incorporation was highly significant (r=0.95, p less than 0.001). Peritoneal dialysis patients on the whole have a normally functioning iron absorption. However, due to increased iron losses and insufficient dietary iron intake, the maintenance of a satisfactory iron balance implies an adequate oral iron supplementation.

Absorption↗
PubMed1979

Menstrual characteristics of 2,343 women attending the Shepherd Foundation.

Menstrual characteristics of 2,343 women attending the Shepherd Foundation Health Testing Centre have been analyzed utilizing a computer system of data analysis. The incidence of menstrual pain was 43% and premenstrual tension 75%. The best estimate of normal cycle length was 21-35 days, 1.5% of women having cycles less than 21 days. The duration of menstrual loss was 1-7 days, 3% of women bleeding for more than 7 days. Utilizing the various responses to questions concerning menstrual and cycle length, menstrual pain and premenstrual tension, 150 patterns were found, the 10 most common patterns accounting for 40% of the population; most of the latter patterns included menstrual pain and premenstrual tension. Authorities disagree upon the definitions of normal menstruation and there are serious implications from the lack of knowledge in this area, both for the individual patient and the cost of health care. The formation of a health committee to determine national standards for defining normal menstruation is advocated.

Adolescent↗
PubMed1979

Social and psychological factors in relation to premenstrual tension and menstrual pain.

Age, country of birth, marital status, attitude to work, smoking and drinking habits, childbearing, sex life and psychological factors are all linked to the frequency of menstrual pain and premenstrual tension. The relationship between the psychosocial and menstrual characteristics may be causal or related to some other constitutional factor (or factors) which determines both. The profile of women suffering from premenstrual tension and menstrual pain is described. In management, associated psychosocial factors and the relationship betweem these and the described menstrual problems needs to be taken into account.

Adolescent↗
PubMed1979

Duration of menstruation.

Menstrual length was analysed in 2,342 women attending the Shepherd Foundation. Prolonged menses were more common in Australian and New Zealand born, in women with irregular, short or long menstrual cycles, menstrual pain, high parity, and an intrauterine device. In contrast to women with premenstrual tension and menstrual pain, psychological factors, smoking and drinking were not more common in women with increased menstrual length. It is concluded that somatic factors alone control menstrual length, and results in the present study support the hypotheses that both the hypothalamic-pituitary system and prostaglandins may be involved in this control. Evidence was found that the use of the contraceptive pill reduces the incidence of premenstrual tension when menstrual length is also reduced.

Contraception↗
PubMed1979

Folate deficiency in chronic inflammatory bowel diseases.

In a consecutive study of 216 outpatients with chronic inflammatory bowel diseases (CIBD) low serum and erythrocyte folate levels were found in 59% and 26%, respectively. In patients with low folate levels in both serum and erythrocytes, megaloblastic changes in the bone marrow ere found in 67% (29 out of 44). Their folate intakes were borderline. Absorption studies with tritiated folate showed low absorption values on repeated examinations in 23% of the patients with low folate values (9 out of 40), with no relationship to the intake of salazosulphapyridine. In patients with low folate values the reticulocyte count was elevated (related to the dose of salazosulphapyridine), and the 51Cr erythrocyte survival was decreased. It is suggested that folate deficiency in CIBD is of multiple origin: inadequate diet, malabsorption, and chronic drug-induced low-grade haemolysis. The clinical consequence of the findings remains to be evaluated.

Bone Marrow↗
PubMed1976

Iron absorption in patients with chronic uremia undergoing regular hemodialysis.

Gastrointestinal iron absorption has been measured by whole body counting in 17 patients with chronic uremia undergoin regular hemodialysis. Absorption was expressed as whole body retention 14 days after oral administration of 10 muCi 59Fe together with a carrier dose of 10 mg Fe2+. The percentage incorporation in the total erythrocyte mass of administered 59Fe (erythrocyte incorporation) and absorbed 59Fe (red cell utilization) was estimated as well. Geometric mean iron absorption was 14.3 +/- 2.0 (S.D.)% and significantly higher than the value obtained in a normal control group (p less than 0.03). Geometric mean erythrocyte incorporation was 11.6 +/- 2.3 (S.D.)% and arithmetic mean red cell utilization was 84.4 +/- 6.0 (S.E.M.)%. Neither of these parameters differed from corresponding values in the control group (p greater than 0.1 and p greater than 0.2, respectively). The correlation between iron absorption and erythrocyte incorporation was highly significant (r=0.94, p less than 0.001). Patients on regular hemodialysis are subjected to considerable iron loss which should be treated by iron supplementation; oral iron administration is recommended in view of the adequate gastrointestinal absorption.

Adult↗
PubMed1976

Iron absorption after renal transplantation.

Gastrointestinal iron absorption has been measured by means of whole body counting in 13 patients after renal allotransplantation. Whole body retention 14 days after oral administration of 10 muCi 59Fe together with a carrier dose of 9.9 mg Fe2+ was used as an expression of absorption. The percentage incorporation in the total erythrocyte mass of administered 59Fe (erythrocyte incorporation) and absorbed 59Fe (red cell utilization) was estimated as well. Geometric mean iron absorption was 12.4 +/- 2.5 (S.D.)% and geometric mean erythrocyte incorporation 11.1 +/- 3.0 (S.D.)% while arithmetic mean red cell utilization was 95.6 +/- 8.6 (S.E.M.)%. None of these parameters differed significantly from those obtained in normal subjects (p greater than 0.2, p greater than 0.1, pgreater than 0.3, respectively). Iron absorption and erythrocyte incorporation in renal transplanted patients did not differ significantly from the values measured in non-dialysed and dialysed patients with chronic renal failure (p greather than 0.1). The correlation between iron absorption and erythrocyte incorporation was highly significant (r = 0.96, p less than 0.001).

Adult↗
PubMed1975

Normal iron absorption determined by means of whole body counting and red cell incorporation of 59Fe.

Gastrointestinal iron absorption has been measured in 27 apparently healthy subjects (8 males and 19 females) by means of whole body counting. Whole body retention 14 days after oral administration of 10 muCi59Fe with a carrier dose of 9.9 mg Fe2+ was used as an expression of absorption. The percentage incorporation of the orally applied 59Fe into the total erythrocyte mass within 14 days (erythrocyte incorporation) was estimated as well. Geometric mean iron absorption was 9.1 +/- 2.2 (S.D.) % in males and 8.3 +/- 2.1% in females; in the entire series it was 8.5 +/- 2.1%. The difference between males and females was not significant. Arithmetic mean red cell utilization of absorbed 59Fe was 92.9 +/- 4.0 (S.E.M.) % in the entire series. The correlation between iron absorption and erythrocyte incorporation was found to be highly significant (r=0.96, p less than 0.001).

Adult↗